Evaluation of the small intestine by MR imaging

New Techniques in Gastrointestinal Imaging

Volumn , Issue , 2004, Pages 203-228

  Gourtsoyiannis, Nicholas C ^a   Papanikolaou, Nickolas ^a  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33644563662     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (43)

1. Dixon PM, Roulston ME, Nolan DJ. The small bowel enema: a 10-year review. Clin Radiol 1993; 4:46-48.
2. Barloon TJ, Lu CC, Honda H, et al. Does a normal small bowel enteroclysis exclude small bowel disease? A long term follow-up of concecutive normal studies. Abdom Imaging 1994; 19:113-115.
3. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn’s disease. Am J Roentgenol 1996; 167:3-15.
4. Bender GN, Maglinte DT, Kloeppel VR, Timmons JH. CT enteroclysis: a superfuous diagnostic procedure or valuable when investigating small bowel disease. AJR 1999; 172:373-378.
5. Rust GF, Holzknecht N, Olbrich D, Schopf U, Bruning R, Reiser M. Multislice computed tomography of the small intestine. Preliminary results. Radiologe 1999; 39(11):965-970.
6. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T, Prassopoulos P. Magnetic resonance imaging of the small bowel usingatrue-FISP sequence after enteroclysis with water solution. Invest Radiol 2000; 35(12):707-711.
7. Lomas DJ, Graves MJ. Small bowel MRI using water as a contrast medium. BJR 1999; 72:994-997.
8. Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H. Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 2000; 215:717-7125.
9. Holzknecht N, Helmberger T, v. Ritter C, Gauger J, Faber S, Reiser M. Breathhold MRI ofthe small bowel in Crohn’s disease after enteroclysis with oral magnetic particles. Radiologe 1998; 38: 29-36.
10. Rieber A, Wruk D, Nussle K, Aschoff AJ, Reinshagen M, Adler G, Brambs H-J, Tomczak R. MRI of the abdomen in combination with enteroclysis in Crohn’s disease with oral and intravenous Gd-DTPA. Radiologe 1998; 38:23-28.
11. Low RN, Francis IR. MR Imaging of gastrointestinal tract with IV Gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT. Am J Roentgenol 1997; 169:1051-1059.
12. Schunk K, Metzmann U, Kersjes W, Schadmann-Fischer S, Kreitner KF, Duchmann R, Protzer U, Wanitschke R, Thelen M. Serialobservationin Crohn’s disease: Can hydro-MRI replace follow-through examinations? Fortschr Rontgenstr 1997; 166:389-396.
13. Maccioni F, Viscido A, Broglia L, Marrollo M, Masciangelo R, Caprilli R, Rossi P. Evaluation of Crohn’s disease activity with magnetic resonance imaging. Abdom Imaging 2000; 25:219-228.
14. Minowa O, Ozaki Y, Kyogoku S, Shindoh N, Sumi Y, Katayama H. MR Imaging of the small bowel using water as a contrast agent in a preliminary study with healthy volunteers. Am J Roentgenol 1999; 173:581-582.
15. Kivelitz D, Gehl HB, Heuck A, Krahe T, Taupitz M, Lodemann KP, Hamm B. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy. Acta Radiol 1999; 40:429-435.
16. Kressel HY. Insights of an abdominal imager: What do we need for MRI enhancement? Magn Reson Med 1991; 22:314.
17. Paley MR, Ros PR. MRI of the gastrointestinaltract. Eur Radiol 1997; 7:1387.
18. Hahn PF. Advances in contrast enhanced MR imaging. Gastrointestinal contrast agents. Am J Roentgenol 1991; 156:252.
19. Small WC, De Simone-Macchi D, Parker JR, et al. A multisite phase III study of the safety and eicacy of a new manganese choride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis. JMRI 1999; 10:15-24.
20. Mirowitz SA, Susmann N. Use of a nutritional support formula as a gastrointestinal contrast agent for MRI. J Comput Assist Tomogr 1992; 16:908.
21. Karantanas A, Papanikolaou N, Kalef-Ezra J, Challa A, Gourtsoyiannis N. Blueberry juice used per os in upper abdominal MR imaging: composition and initial clinical data. Eur Radiol 2000; 10:909-913.
22. Rubin DL, Muller HH, Young SW. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: efects of barium sulfate additive on MR contrast agent efectiveness. Magn Reson Med 1992; 23:154.
23. Faber SC, Stehling MK, Holzknecht N, Gauger J, Helmberger T, Reiser M. Pathologic conditions in the small bowel: indings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles. Radiology 1997; 205:278-282.
24. Mitchell DG, Vinitski S, Mohamed FB, Mammone JF, Haidet K, Rifkin MD. Comparison of Kaopectate with barium for negative and positive enteric contrast at MR Imaging. Radiology 1991; 181:475-480.
25. Mattrey RF, Trambert MA, Brown JJ, Young SW, Bruneton JN, Wesbey GE, Balsara ZN. Perflubron as an oral contrast agent for MR imaging: results of aphase III clinical trial. Radiology 1994; 191:841-848.
26. Weinreb JC, Maravilla KR, Redman HC, Nunnally R. Improved MR imaging of the upper abdomen with glucagons and gas. J Comput Assist Tomogr 1984; 8:835-838.
27. Reiber A, Aschoff A, Nussle K, Wruk D, Tomczak R, Reinshagen M, Adler G, Brambs HJ. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 2000; 10(9):1377-1382.
28. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T, Prassopoulos P. MR Enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences. Eur Radiol 2001; 11(6):908-913.
29. Schunk K, Kern A, Oberholzer K, Kalden P, Mayer I, Orth T, Wanitschke R. Hydro-MRI in Crohn’s disease. Appraisal of disease activity. Invest Radiol 2000; 35:431-437.
30. Semelka RC, John G, Kelekis N, Burdeny DA, Ascher SM. Small bowel neoplastic disease: demonstration by MRI. JMRI 1996; 6:855-860.
31. Papanikolaou N, Prassopoulos P, Grammatikakis J, Maris T, Kouroumalis E, Gourtsoyiannis N. Optimization of a contrast medium suitable for conventional enteroclysis, MR enteroclysis, and virtual MR enteroscopy. Abdom Imaging 2002; 27(5):517-522.
32. Haacke M, Tkach J. Fast MR imaging: techniques and clinical applications. AJR 1990; 155:951-964.
33. Oppelt A, Graumann R, Barfuss H, Fischer H, Hertl W, Schajor W. A new fast MRI sequence. Electromed 1986; 3:15-18.
34. Laubenberger J, Buchert M, Schneider B, Blum U, Hennig J, Langer M. Breath-hold projection magnetic resonance-cholangio-pancreaticography (MRCP): a new method for the examination ofthe bile and pancreatic ducts. Magn Reson Med 1995; 33(1):18-23.
35. Papamastorakis G, Papanikolaou N, Prassopoulos P, Grammatikakis J, Maris T, Gourtsoyiannis N. Crohn’s disease: comparison between MR enteroclysis and conventional enteroclysis. In book of abstracts; ECR 2003 B-0368, pp 208.
36. Prassopoulos P, Papanikolaou N, Grammatikakis J, Roussomoustakaki M, Maris T, Gourtsoyiannis N. MR Enteroclysis imaging indings in Crohn’s disease. Radiographics 2001; 21:S161-S172.
37. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Prassopoulos P. MR enteroclysis: technical considerations and clinical applications. Eur Radiol 2002; 12(11):2651-2658.
38. Tritou I, Papanikolaou N, Prassopoulos P, Grammatikakis I, Roussomousta-kaki M, Gourtsoyiannis N. Crohn’s disease activity assessment with MR enteroclysis. Inbook of abstracts; ECR2003, B-0654, pp 272.
39. Gourtsoyiannis N, Papanikolaou N, Rieber A, Brambs HJ, Prassopoulos P. Evaluation of the small intestine by MR imaging. In: Gourtsoyiannis N, ed. Radiological Imaging of the Small Intestine. New York: Springer-Verlag, 2002:157-170.
40. Lienemann A, Sprenger D, Steitz HO, Korell M, Reiser M. Detection and mapping of intraabdominal adhesions by using functional cine MR imaging: preliminary results. Radiology 2000; 217:421-425.
41. Ha HK, Lee EH, Lim CH, Shin YM, Jeong YK, Yoon KH, Lee MG, Min Y, Auh YH. Application of MRI for small intestinal diseases. JMRI 1998; 8:375-383.
42. Li KCP, Whitney WS, McDonnell CH, et al. Chronic mesenteric ischemia: evaluation with phase-contrast cine MR imaging. Radiology 1994; 190: 175-179.
43. Hiliker PR, Weishaupt D, Kacl GM, Hetzer FH, Grif MD, Ruehm SG, Debatin JF. Comparison of three dimensional magnetic resonance imaging in conjunction with a blood pool contrast agent and nuclear scintigraphy for the detection of experimentally induced gastrointestinal bleeding. Gut 1999; 45(4):581-587.